検索タンパク質、抗体、アッセイキット
タンパク質カタログ
輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。
- サプライヤー
- TargteMol
- カタログNo.
- TMPY-05365
- 製品名称
- BAFF/TNFSF13B Protein, Human, Recombinant (Avi & Fc), Biotinylated
- タンパク質名
- BAFF/TNFSF13B
- Species
- Human
- HOST
- HEK293 Cells
- 20μg: -
- お問い合わせ
Overview
| Synonyms | TNFSF20, TALL-1, DTL, BLYS, THANK, tumor necrosis factor (ligand) superfamily, member 13b, ZTNF4, TALL1, CD257, BAFF |
|---|---|
| Characteristics | Immobilized Human BCMA Protein (His & hFc Tag) at 2 μg/mL (100 μL/well) can bind Human BAFF/BLyS Protein (ECD, hFc & AVI Tag), Biotinylated , the EC50 is 2-16ng/mL. |
| Endotoxin Level | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Purity | 90.50% |
| Description | BAFF/TNFSF13B Protein, Human, Recombinant (Avi & Fc), Biotinylated is expressed in HEK293 mammalian cells with AVI and Fc tag. The predicted molecular weight is 45.6 kDa and the accession number is A0A0U5J7Q1. |
| Reference | Cancro MP,et al.(2009) The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest. 119(5): 1066-73.,Stohl W. (2006) Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseases. Endocr Metab Immune Disord Drug Targets. 6(4): 51-8.,Nardelli B,et al.(2002) B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases. Leuk Lymphoma. 43(7): 1367-73. |
| URL | https://www.targetmol.com/recombinant-protein/baff_blys_protein_human_recombinant_ecd_avi_fc_tag_biotinylated |
お問い合わせリスト